Literature DB >> 19130475

IL-4 blocks M-CSF-dependent macrophage proliferation by inducing p21Waf1 in a STAT6-dependent way.

Luis Arpa1, Annabel F Valledor, Jorge Lloberas, Antonio Celada.   

Abstract

Macrophages are recruited from the blood stream to the inflammatory loci to carry out their functional activities. In an early phase of the cell cycle, macrophages become activated by Th1-type cytokines (i.e. IFN-gamma), thereby producing several factors (cytokines, NO, etc.) and developing pro-inflammatory activities. When bacteria and apoptotic bodies are removed, through the interaction with Th2-type cytokines (i.e. IL-4), macrophages become anti-inflammatory and repair damaged tissues. Incubation of bone-marrow-derived macrophages with IFN-gamma or IL-4 blocked their proliferation. While M-CSF withdrawal caused cell cycle arrest at the early G(1) phase, treatment of macrophages with IFN-gamma or IL-4 caused this arrest later, at the G(1)/S boundary. Proliferation arrest was not due to an induction of apoptosis. IFN-gamma and IL-4 induced the expression of the cyclin-dependent kinase (Cdk) inhibitor p21(Waf1). Using KO mice and iRNA experiments, we found that p21(Waf1)is required for IL-4- but not for IFN-gamma-dependent inhibition of macrophage proliferation. IL-4 inhibited M-CSF-dependent Cdk-2 and Cdk-4 activities, which are necessary for entry and passage through the S phase of the cell cycle. The signal transduction used to induce the expression of p21(Waf1)after interaction of IL-4 with the corresponding receptor was mediated by STAT6. Thus, IL-4 and IFN-gamma blocked M-CSF-induced macrophage proliferation through distinct mechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19130475     DOI: 10.1002/eji.200838283

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  22 in total

1.  Hepatitis C Virus E2 Envelope Glycoprotein Induces an Immunoregulatory Phenotype in Macrophages.

Authors:  Young-Chan Kwon; Keith Meyer; Guangyong Peng; Soumya Chatterjee; Daniel F Hoft; Ranjit Ray
Journal:  Hepatology       Date:  2018-05-24       Impact factor: 17.425

2.  Inhibition of Cyclin-Dependent Kinase 9 Downregulates Cytokine Production Without Detrimentally Affecting Human Monocyte-Derived Macrophage Viability.

Authors:  Brian J McHugh; Jillian Stephen; Calum T Robb; Sarah Fox; Tiina Kipari; Jennifer A Cartwright; Christopher Haslett; Rodger Duffin; Christopher D Lucas; Adriano G Rossi
Journal:  Front Cell Dev Biol       Date:  2022-05-26

3.  Fully human MAP-fusion protein selectively targets and eliminates proliferating CD64(+) M1 macrophages.

Authors:  Dmitrij Hristodorov; Radoslav Mladenov; Rainer Fischer; Stefan Barth; Theo Thepen
Journal:  Immunol Cell Biol       Date:  2016-01-08       Impact factor: 5.126

Review 4.  CSF-1R signaling in health and disease: a focus on the mammary gland.

Authors:  Amy Renee Sullivan; Fiona Jane Pixley
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-06-10       Impact factor: 2.673

5.  Interleukin-4 induces senescence in human renal carcinoma cell lines through STAT6 and p38 MAPK.

Authors:  Hag Dong Kim; Su-Jin Yu; Hee Suk Kim; Yong-Jin Kim; Jeong Min Choe; Yun Gyu Park; Joon Kim; Jeongwon Sohn
Journal:  J Biol Chem       Date:  2013-08-09       Impact factor: 5.157

6.  Stat6 cooperates with Sp1 in controlling breast cancer cell proliferation by modulating the expression of p21(Cip1/WAF1) and p27 (Kip1).

Authors:  Min Wei; Bingya Liu; Qinlong Gu; Liping Su; Yingyan Yu; Zhenggang Zhu
Journal:  Cell Oncol (Dordr)       Date:  2012-11-27       Impact factor: 6.730

7.  In vivo inhibition of c-MYC in myeloid cells impairs tumor-associated macrophage maturation and pro-tumoral activities.

Authors:  Oscar M Pello; Raphael Chèvre; Damya Laoui; Alba De Juan; Fidel Lolo; María Jesús Andrés-Manzano; Manuel Serrano; Jo A Van Ginderachter; Vicente Andrés
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

8.  Circulating cytokine profiles and their relationships with autoantibodies, acute phase reactants, and disease activity in patients with rheumatoid arthritis.

Authors:  Pieter W A Meyer; Bridget Hodkinson; Mahmood Ally; Eustasius Musenge; Ahmed A Wadee; Heidi Fickl; Mohammed Tikly; Ronald Anderson
Journal:  Mediators Inflamm       Date:  2011-03-02       Impact factor: 4.711

9.  A polymorphism in the interleukin-4 receptor affects the ability of interleukin-4 to regulate Th17 cells: a possible immunoregulatory mechanism for genetic control of the severity of rheumatoid arthritis.

Authors:  Susan K Wallis; Laura A Cooney; Judith L Endres; Min Jie Lee; Jennifer Ryu; Emily C Somers; David A Fox
Journal:  Arthritis Res Ther       Date:  2011-02-04       Impact factor: 5.156

10.  Dendritic cells enhance the activity of human MUC1-stimulated mononuclear cells against breast cancer.

Authors:  Zhenyao Wang; Monte D Hall; Kathleen A Rewers-Felkins; Imelda S Quinlin; Stephen E Wright
Journal:  Oncoimmunology       Date:  2013-02-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.